Biocon Biologics: US Biosimilars Are A Marathon, Not A Sprint
Chief Commercial Officer For Advanced Markets Matt Erick Emphasizes Commitment To Sector
• By David Wallace
Erick says the biosimilars race is “not going to be won in the short term” • Source: Shutterstock 
